Breaking News

DaVita Expands Central Lab Services

Increases test menu by 43%

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

DaVita Clinical Research (DCR) is expanding its Central Laboratory services. The company’s test menu will increase by 43%, maintaining its position in advanced renal care as well as coverage in the areas of oncology, immunology, endocrinology, cardiology and anemia. DCR’s Central Lab is focused on providing clinical research in both complex/specialty populations and therapeutic areas, as well as chronic kidney disease (CKD) populations.   The testing facility has added two new testing platforms...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters